Search
for
Sort by
Research 481–510 of 1000+
- The Association of Hispanic Ethnicity with Nonalcoholic Fatty Liver Disease in Polycystic Ovary Syndrome
- Nesfatin-1 and Vitamin D levels may be associated with systolic and diastolic blood pressure values and hearth rate in polycystic ovary syndrome
- Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy
- The selective androgen receptor modulator GTx‐024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double‐blind, placebo‐controlled phase II trial
- Polycystic ovary syndrome and its management: In view of oxidative stress
- A randomized placebo-controlled study on the effects of pioglitazone on cortisol metabolism in polycystic ovary syndrome
- Male Equivalent Polycystic Ovarian Syndrome: Hormonal, Metabolic, and Clinical Aspects.
- Metabolic syndrome and dermatological diseases: association and treatment
- The Role of Probiotics and Synbiotics on Hirsutism
- Metabolic Syndrome, Hepatic Steatosis and Testosterone: A Matter of Sex
- Association of severity of menstrual dysfunction with cardiometabolic risk markers among women with polycystic ovary syndrome
- The Role of Hormones in Hidradenitis Suppurativa: A Systematic Review
- Cardiometabolic Risk Factors in Atorvastatin-Treated Women with Euthyroid Autoimmune Thyroiditis
- Women with PCOS have a heightened risk of cardiometabolic and cardiovascular diseases: statement from the Experts Group on Inositol in Basic and Clinical Research and PCOS (EGOI-PCOS) and Italian Association of Hospital Cardiologists (ANMCO)
- GLP-1 Receptor Analogs: Evidence Linking to Effect on Metabolic and Reproductive Functions in Patients with PCOS and Obesity
- Immunological and Metabolic Causes of Infertility in Polycystic Ovary Syndrome
- Machine learning-based steroid metabolome analysis reveals three distinct subtypes of polycystic ovary syndrome and implicates 11-oxygenated androgens as major drivers of metabolic risk
- Exercise in the management of polycystic ovary syndrome: A position statement from Exercise and Sports Science Australia
- Pathophysiology and Nutritional Approaches in Polycystic Ovary Syndrome (PCOS): A Comprehensive Review
- Are ABO/Rh blood groups A risk factor for polycystic ovary syndrome?
- Androgenetic Alopecia in Polycystic Ovary Syndrome: A Cutaneous Marker of Systemic Metabo-inflammatory and Endocrine Dysfunction: A Narrative Review
- Skin as a Metabolic Organ: Dermatologic Markers of Morbid Obesity and Their Role in Risk Stratification and Treatment Monitoring
- Vitamin D Adequacy Conditions the Prolactin-Suppressive Effect of Metformin in Men Receiving Prolactin-Elevating Medications
- Optimizing Nutrition for PCOS Management: A Comprehensive Guide
- The Current and Emerging Role of Statins in the Treatment of PCOS: The Evidence to Date
- The Potential Utility of Tirzepatide for the Management of Polycystic Ovary Syndrome
- Exercise activates the PI3K-AKT signal pathway by decreasing the expression of 5α-reductase type 1 in PCOS rats
- Cardiovascular Risk Factors in Bulgarian Patients with Polycystic Ovary Syndrome and/or Obesity
- Polycystic ovary syndrome [PCOS]: Comprehensive management in primary care
- Androgen Therapy in Women: An Endocrine Society Clinical Practice Guideline